Betaferon(R) Approved In Australia For Earliest Stages Of Multiple Sclerosis

... Schering AG, Germany (FSE: SCH, NYSE: SHR), majority-owned by the Bayer Group, announced today that the Australian Therapeutic Goods Administration has expanded the indication of Betaferon(R) (interferon beta-1b) to include patients with a first clinical event suggestive of multiple sclerosis (MS). [click link for full article] ...